Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895427 · ClinicalTrials.gov registry record
A Study Comparing Skin Fluorescence to Coronary Artery Calcification
A clinical trial of Diabetes and Coronary Artery Calcification, sponsored by VeraLight.
- Completed
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT00895427: Completed study of Diabetes and Coronary Artery Calcification, sponsored by VeraLight.
NCT00895427 is a study of Diabetes and Coronary Artery Calcification that has completed, run by VeraLight. The registered enrollment target is 240 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00895427, a study of Diabetes and Coronary Artery Calcification, has completed, sponsored by VeraLight.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.
Conditions Studied
Study Locations (1)
New Mexico
- New Mexico Heart Institute - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-09 |
What the finished NCT00895427 record still lists
NCT00895427 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT00895427 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT00895427 about?
NCT00895427 is a clinical study titled "A Study Comparing Skin Fluorescence to Coronary Artery Calcification". This study examines the relationship between the SCOUT DM device and coronary artery calcification as determined by rapid computed tomography in patients at risk for coronary heart disease.
What is the current status of trial NCT00895427?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2009-02. Estimated completion is 2011-09.
What conditions does trial NCT00895427 study?
This clinical trial studies the following conditions: Diabetes, Coronary Artery Calcification.
Who is sponsoring clinical trial NCT00895427?
This trial is sponsored by VeraLight, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00895427 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00895427's enrollment target sits among peer trials
240 133rd of 338 higher than 203 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia